Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sexton

Showing results (461-470 of 518) with videos related to

Pageof 52
Sort By:
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H<sub>3</sub> receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience|December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric ActivityManuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
Journal of the American Chemical Society|August 17, 2019
O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo ActivityPaul M Levine, Aaron T Balana, Emmanuel Sturchler, et al.
Biochemical Pharmacology|August 2, 2021
Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptorElita Yuliantie, Wijnand J C van der Velden, Viktorija Labroska, et al.
Nature Chemical Biology|March 6, 2023
Author Correction: Structural basis of efficacy-driven ligand selectivity at GPCRsAlexander S Powers, Vi Pham, Wessel A C Burger, et al.
Nature Chemical Biology|February 13, 2023
Structural basis of efficacy-driven ligand selectivity at GPCRsAlexander S Powers, Vi Pham, Wessel A C Burger, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2006
Functional selectivity and classical concepts of quantitative pharmacologyJonathan D Urban, William P Clarke, Mark von Zastrow, et al.
Plos Biology|June 4, 2021
Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivityJesse I Mobbs, Matthew J Belousoff, Kaleeckal G Harikumar, et al.
Nature Chemical Biology|August 3, 2023
Structural insight into selectivity of amylin and calcitonin receptor agonistsJianjun Cao, Matthew J Belousoff, Elliot Gerrard, et al.
Pageof 52

Showing results (461-470 of 518) with videos related to

Sort By:
Pageof 52
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H<sub>3</sub> receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience|December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric ActivityManuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
Journal of the American Chemical Society|August 17, 2019
O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo ActivityPaul M Levine, Aaron T Balana, Emmanuel Sturchler, et al.
Biochemical Pharmacology|August 2, 2021
Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptorElita Yuliantie, Wijnand J C van der Velden, Viktorija Labroska, et al.
Nature Chemical Biology|March 6, 2023
Author Correction: Structural basis of efficacy-driven ligand selectivity at GPCRsAlexander S Powers, Vi Pham, Wessel A C Burger, et al.
Nature Chemical Biology|February 13, 2023
Structural basis of efficacy-driven ligand selectivity at GPCRsAlexander S Powers, Vi Pham, Wessel A C Burger, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2006
Functional selectivity and classical concepts of quantitative pharmacologyJonathan D Urban, William P Clarke, Mark von Zastrow, et al.
Plos Biology|June 4, 2021
Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivityJesse I Mobbs, Matthew J Belousoff, Kaleeckal G Harikumar, et al.
Nature Chemical Biology|August 3, 2023
Structural insight into selectivity of amylin and calcitonin receptor agonistsJianjun Cao, Matthew J Belousoff, Elliot Gerrard, et al.
Pageof 52